ArticleNaunyn-Schmiedeberg's archives of pharmacology2025
FOXD1-activated ANXA3 facilitates cisplatin resistance of lung cancer cells via promoting ANXA4 expression.
Qing Tan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it